RHY Announcement extract - April 2, 2020
“Despite the current macroeconomic climate, I would remind all stakeholders that in addition
to potentially replacing or working as an adjunct< of the current faecal testing, the ColoSTAT®
test kit will enable the reading of cancerous samples, rather than just the presence of blood
in faeces. More so, we believe a simple blood test should improve the current poor compliance
record of the faecal immunochemical test (FIT), saving lives and healthcare costs globally,”
said Mr Gilbert.
“We strongly believe ColoSTAT® has a global market, whereby the ColoSTAT® test could be
added to the standard panel of blood tests a GP may run for their patients as part of their
annual check-up. Further, once approved, ColoSTAT® has the potential to attract
reimbursement by both governments and health insurance companies worldwide” Mr Gilbert
said.
- Forums
- ASX - By Stock
- RHY
- Ann: Rhythm Maintains Ongoing ISO13485 Certification
Ann: Rhythm Maintains Ongoing ISO13485 Certification, page-22
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.16M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 547 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.2¢ | 48450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 547 | 0.061 |
2 | 120000 | 0.060 |
1 | 40000 | 0.059 |
4 | 268924 | 0.058 |
2 | 22855 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.062 | 48450 | 1 |
0.066 | 79998 | 1 |
0.070 | 415394 | 3 |
0.071 | 150525 | 1 |
0.072 | 2245 | 1 |
Last trade - 16.12pm 18/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
Day chart unavailable